sorafenib has been researched along with 1-anilino-8-naphthalenesulfonate in 3 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (1-anilino-8-naphthalenesulfonate) | Trials (1-anilino-8-naphthalenesulfonate) | Recent Studies (post-2010) (1-anilino-8-naphthalenesulfonate) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 24,275 | 480 | 7,815 |
| Protein | Taxonomy | sorafenib (IC50) | 1-anilino-8-naphthalenesulfonate (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, W; Kan, Q; Li, Y; Tian, X; Wang, S; Wei, H; Yang, Z | 1 |
| Akaza, H; Murai, M; Naito, S; Nakajima, K; Tsukamoto, T | 1 |
| Adachi, M; Akaza, H; Hyodo, I; Murai, M; Naito, S; Tsukamoto, T | 1 |
1 review(s) available for sorafenib and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
Topics: Animals; Crystallography, X-Ray; Cyclin-Dependent Kinases; Humans; Molecular Structure; Protein Binding; Protein Kinase Inhibitors | 2019 |
2 trial(s) available for sorafenib and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Benzenesulfonates; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Eruptions; Female; Humans; Kidney Neoplasms; Lipase; Male; Middle Aged; Nephrectomy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib | 2007 |
[Serum pancreatic enzyme elevation under treatment with sorafenib].
Topics: Adult; Aged, 80 and over; Amylases; Benzenesulfonates; Humans; Lipase; Male; Middle Aged; Niacinamide; Pancreas; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib | 2012 |